Skip to content

Clinical trials

Phase 3 Carcinoma, Squamous Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 3 Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20081
20101
20111
20141
20161
20173
20191
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
BioVex Limited1
Celgene1
Galderma R&D1
Genzyme, a Sanofi Company1
Incyte Corporation1
Johnson & Johnson Enterprise Innovation Inc.1
LEO Pharma1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell14
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Large Cell3
Keratosis, Actinic3
Squamous Cell Carcinoma of Head and Neck3
Adenocarcinoma2
Carcinoma2
Head and Neck Neoplasms2
Lung Neoplasms2
Neoplasm Metastasis2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.